Nordberg A - Search Results

1

Recruitment of pre-dementia participants: main enrollment barriers in a longitudinal amyloid-PET study.

Bader I, Bader I, Lopes Alves I, Vállez García D, Vellas B, Dubois B, Boada M, Marquié M, Altomare D, Scheltens P, Vandenberghe R, Hanseeuw B, Schöll M, Frisoni GB, Jessen F, Nordberg A, Kivipelto M, Ritchie CW, Grau-Rivera O, Molinuevo JL, Ford L, Stephens A, Gismondi R, Gispert JD, Farrar G, Barkhof F, Visser PJ, Collij LE; AMYPAD consortium. Bader I, et al. Among authors: nordberg a. Alzheimers Res Ther. 2023 Nov 2;15(1):189. doi: 10.1186/s13195-023-01332-4. Alzheimers Res Ther. 2023. PMID: 37919783 Free PMC article.

2

Glucose metabolism and PIB binding in carriers of a His163Tyr presenilin 1 mutation.

Schöll M, Almkvist O, Axelman K, Stefanova E, Wall A, Westman E, Långström B, Lannfelt L, Graff C, Nordberg A. Schöll M, et al. Among authors: nordberg a. Neurobiol Aging. 2011 Aug;32(8):1388-99. doi: 10.1016/j.neurobiolaging.2009.08.016. Epub 2009 Sep 30. Neurobiol Aging. 2011. PMID: 19796846

3

Time course of glucose metabolism in relation to cognitive performance and postmortem neuropathology in Met146Val PSEN1 mutation carriers.

Schöll M, Almkvist O, Bogdanovic N, Wall A, Långström B, Viitanen M, Nordberg A. Schöll M, et al. Among authors: nordberg a. J Alzheimers Dis. 2011;24(3):495-506. doi: 10.3233/JAD-2011-101563. J Alzheimers Dis. 2011. PMID: 21297272

4

Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG.

Carter SF, Schöll M, Almkvist O, Wall A, Engler H, Långström B, Nordberg A. Carter SF, et al. Among authors: nordberg a. J Nucl Med. 2012 Jan;53(1):37-46. doi: 10.2967/jnumed.110.087031. J Nucl Med. 2012. PMID: 22213821 Free article.

5

Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers.

Schöll M, Wall A, Thordardottir S, Ferreira D, Bogdanovic N, Långström B, Almkvist O, Graff C, Nordberg A. Schöll M, et al. Among authors: nordberg a. Neurology. 2012 Jul 17;79(3):229-36. doi: 10.1212/WNL.0b013e31825fdf18. Epub 2012 Jun 13. Neurology. 2012. PMID: 22700814

6

Combination of 18F-FDG PET and cerebrospinal fluid biomarkers as a better predictor of the progression to Alzheimer's disease in mild cognitive impairment patients.

Choo IH, Ni R, Schöll M, Wall A, Almkvist O, Nordberg A. Choo IH, et al. Among authors: nordberg a. J Alzheimers Dis. 2013;33(4):929-39. doi: 10.3233/JAD-2012-121489. J Alzheimers Dis. 2013. PMID: 23047371

7

Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease.

Prestia A, Caroli A, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen CE, Wall AE, Carter SF, Schöll M, Choo IH, Nordberg A, Scheltens P, Frisoni GB. Prestia A, et al. Among authors: nordberg a. Neurology. 2013 Mar 12;80(11):1048-56. doi: 10.1212/WNL.0b013e3182872830. Epub 2013 Feb 6. Neurology. 2013. PMID: 23390179

8

Imaging markers for Alzheimer disease: which vs how.

Frisoni GB, Bocchetta M, Chételat G, Rabinovici GD, de Leon MJ, Kaye J, Reiman EM, Scheltens P, Barkhof F, Black SE, Brooks DJ, Carrillo MC, Fox NC, Herholz K, Nordberg A, Jack CR Jr, Jagust WJ, Johnson KA, Rowe CC, Sperling RA, Thies W, Wahlund LO, Weiner MW, Pasqualetti P, Decarli C; ISTAART's NeuroImaging Professional Interest Area. Frisoni GB, et al. Among authors: nordberg a. Neurology. 2013 Jul 30;81(5):487-500. doi: 10.1212/WNL.0b013e31829d86e8. Neurology. 2013. PMID: 23897875 Free PMC article. Review.

9

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.

Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, Galasko D, Habert MO, Jicha GA, Nordberg A, Pasquier F, Rabinovici G, Robert P, Rowe C, Salloway S, Sarazin M, Epelbaum S, de Souza LC, Vellas B, Visser PJ, Schneider L, Stern Y, Scheltens P, Cummings JL. Dubois B, et al. Among authors: nordberg a. Lancet Neurol. 2014 Jun;13(6):614-29. doi: 10.1016/S1474-4422(14)70090-0. Lancet Neurol. 2014. PMID: 24849862

10

Astrocytosis measured by ¹¹C-deprenyl PET correlates with decrease in gray matter density in the parahippocampus of prodromal Alzheimer's patients.

Choo IL, Carter SF, Schöll ML, Nordberg A. Choo IL, et al. Among authors: nordberg a. Eur J Nucl Med Mol Imaging. 2014 Nov;41(11):2120-6. doi: 10.1007/s00259-014-2859-7. Epub 2014 Jul 31. Eur J Nucl Med Mol Imaging. 2014. PMID: 25077930

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

538 results

Search Page

Filters